Compliance With Recommendations and Opportunities for Vaccination at Ages 11 to 12 Years Evaluation of the 2009 National Immunization Survey-Teen
Compliance With Recommendations and Opportunities for Vaccination at Ages 11 to 12 Years Evaluation of the 2009 National Immunization Survey-Teen
复制标题
DOI：
10.1001/archpediatrics.2011.138
复制
发表时间：
2011-09-01
影响因子：
--
通讯作者：
McCauley, Mary M.
中科院分区：
文献类型：
--
作者：
Stokley, Shannon;Cohn, Amanda;McCauley, Mary M.
目的：确定选定年龄和出生队列的疫苗接种覆盖率，并评估接种访视期间是否接种了所有指定疫苗。设计：基于人群的横断面研究。设置：全国免疫调查-青少年2009年电话访谈。参与者：美国13至17岁的青少年，提供者报告接种史（N=20 066）.主要结果测量：在所有青少年中和按出生队列：三种儿童疫苗的覆盖率估计数（麻疹、B型肝炎和水痘）和3种青少年疫苗（破伤风-白喉和/或破伤风-白喉-无细胞百日咳、含脑膜炎球菌和人乳头瘤病毒的女孩）。到11岁时，大多数青少年已经接种了儿童疫苗。从1991年到1996年，11至12岁儿童接种破伤风-白喉和/或破伤风-白喉-无细胞百日咳疫苗的人数显著增加（33.8%比68.2%，P < .001）;从1993年到1996年，11至12岁儿童接种含脑膜炎球菌疫苗的人数显著增加（8.4%对50.0%，P < .001）。1994年至1996年出生队列中，11至12岁女孩接受人乳头瘤病毒疫苗接种的比例显著增加（11.1%对30.5%，P <0.001）。总体而言，54.9%的青少年在11至12岁时至少接受过一次疫苗接种。在11至12岁进行疫苗接种的青少年中，19.5%没有接种破伤风-白喉和/或破伤风-白喉-无细胞百日咳，60.9%没有接种含脑膜炎球菌的疫苗，62.4%没有接种人乳头瘤病毒疫苗。然而，提供者在接种访问期间通常不施用所有指示的疫苗。
Objectives: To determine vaccination coverage at selected ages and by birth cohort and to assess whether all indicated vaccines were administered during vaccination visits.Design: Population-based cross-sectional study.Setting: National Immunization Survey-Teen 2009 telephone interview.Participants: United States adolescents aged 13 to 17 years with provider-reported vaccination histories (N=20 066).Main Outcome Measures: Among all adolescents and by birth cohort: coverage estimates for 3 childhood vaccines (measles-containing, hepatitis B, and varicella) and 3 adolescent vaccines (tetanus-diphtheria and/or tetanus-diphtheria-acellular pertussis, meningococcal-containing, and human papillomavirus for girls) at selected ages.Results: By age 11 years, most adolescents had obtained the childhood vaccines. Receipt of a tetanus-diphtheria and/or tetanus-diphtheria-acellular pertussis vaccine at ages 11 to 12 years increased significantly from the 1991 to 1996 birth cohort (33.8% vs 68.2%, P < .001); receipt of meningococcal-containing vaccine at ages 11 to 12 years increased significantly from the 1993 to 1996 birth cohort (8.4% vs 50.0%, P < .001). Among girls, receipt of human papillomavirus vaccine at ages 11 to 12 years increased significantly from the 1994 to 1996 birth cohort (11.1% vs 30.5%, P < .001). Overall, 54.9% of adolescents received at least 1 vaccination visit at ages 11 to 12 years. Among adolescents who made a vaccination visit at ages 11 to 12 years and were eligible for vaccination, 19.5% did not receive tetanus-diphtheria and/or tetanus-diphtheria-acellular pertussis, 60.9% did not receive meningococcal-containing, and 62.4% did not receive human papillomavirus vaccines.Conclusions: Receipt of vaccines at the recommended ages of 11 to 12 years appears to be increasing; however, providers often do not administer all indicated vaccines during a vaccination visit.